End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?
Degtyarev E, Bolaños N, Brody JD, Buchbinder A, Buyse M, Fuchs M, Halabi S, Hemmings R, Masood A, Newsome S, Saxton C, Warwick L, Yateman NA, Zuber E.
Degtyarev E, et al. Among authors: masood a.
Future Oncol. 2024 Jun 18:1-15. doi: 10.1080/14796694.2024.2357537. Online ahead of print.
Future Oncol. 2024.
PMID: 38889345